Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Histrelin acetate subcutaneous implant - Endo Pharmaceuticals Solutions

Next Previous
Drug Profile

Histrelin acetate subcutaneous implant - Endo Pharmaceuticals Solutions

Alternative Names: Histrelin implant; LHRH-Hydrogel implant; RL 0903; SPD 424; Supprelin-LA; Vantas; VP 002

Latest Information Update: 27 Apr 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Valera Pharmaceuticals
  • Developer BioPro Pharmaceutical; Endo Pharmaceuticals Solutions; Endo, Inc.; Teva-Tuteur; Valera Pharmaceuticals
  • Class Antineoplastics; Pituitary hormone releasing hormones
  • Mechanism of Action Gonadotropin releasing hormone stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Precocious puberty
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Precocious puberty; Prostate cancer

Most Recent Events

  • 23 Apr 2024 Endo International has been acquired and merged into Endo, Inc.
  • 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
  • 23 Mar 2012 No development reported - Preregistration for Prostate cancer in China (SC)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top